DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
41	巨細胞性動脈炎	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04239196 (ClinicalTrials.gov)	July 1, 2020	19/11/2019	Efficacy of Tocilizumab for the Treatment of Acute AION Related to GCA	Open Label Phase II Randomized Non-comparative Study of SC Tocilizumab Associated With IV Pulse Steroid Versus IV Pulse Steroid Alone for the Treatment of Acute Anterior Ischemic Optic Neuropathy Associated With Giant Cell Arteritis	Giant Cell Arteritis;Optic Ischaemic Neuropathy	Drug: tocilizumab and IV steroids combination;Other: IV steroids combination alone	Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts	Roche Chugai	Not yet recruiting	50 Years	N/A	All	58	Phase 2	France

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT04239196
(ClinicalTrials.gov)

July 1, 2020

19/11/2019

Efficacy of Tocilizumab for the Treatment of Acute AION Related to GCA

Open Label Phase II Randomized Non-comparative Study of SC Tocilizumab Associated With IV Pulse Steroid Versus IV Pulse Steroid Alone for the Treatment of Acute Anterior Ischemic Optic Neuropathy Associated With Giant Cell Arteritis

Giant Cell Arteritis;Optic Ischaemic Neuropathy

Drug: tocilizumab and IV steroids combination;Other: IV steroids combination alone

Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts

Roche Chugai

Not yet recruiting

50 Years

N/A

All

Phase 2

France